6 References 1. Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapidacting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015; 66: 509–523 doi: 10.1146/annurev-med-053013-062946. 2. Highland JN, Zanos P, Riggs LM, Georgiou P, Clark SM, Morris PJ, al. et. Hydroxynorketamine: pharmacology and potential therapeutic applications. Pharmacol Rev. 2021; 73: 763–791 doi: 10.1124/pharmrev.120.000149. 3. Fjendbo Galili S, Nikolajsen L, Papadomanolakis-Pakis N. Subanaesthetic single-dose ketamine as an adjunct to opioid analgesics for acute pain management in the emergency department: a systematic review and metaanalysis. BMJ Open. 2023; 13: e066444 doi: 10.1136/bmjopen-2022-066444. 4. Jonkman K, Dahan A, Donk T van de, Aarts L, Niesters M, Velzen M van. Ketamine for pain. F1000Research. 2017; doi: 10.12688/f1000research.11372.1. 5. Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C. J, Vazquez G, Loo C. Ketamine for the treatment of major depression: a systematic review and meta-analysis. eClinicalMedicine. 2023; 62: 102127 doi: 10.1016/j.eclinm.2023.102127. 6. Boom M, Olofsen E, Neukirchen M, Fussen R, Hay J, Groeneveld GJ, Aarts L, Sarton E, Dahan A. Fentanyl utility function: a risk-benefit composite of pain relief and breathing responses. Anesthesiology. 2013; 119: 663–674 doi: 10.1097/ALN.0b013e31829ce4cb. 7. Sleigh J, Harvey M, Voss L, Denny B. Ketamine - More mechanisms of action than just NMDA blockade. Trends in Anaesthesia & Critical Care. 2014; 4: 76–81 doi: 10.1016/j.tacc.2014.03.002. 127
RkJQdWJsaXNoZXIy MTk4NDMw